Category: Thoughts

Capture2

What’s in a Cigarette and the Tobacco Industry?

Tobacco – people smoke, chew, or sniff to absorb the nicotine in it. The products include cigarettes, cigars, bidis, and more. The tobacco and cigarette production industry faces various challenges in the developed and developing countries. At Infiniti Research, our experts performed a market intelligence study on cigarettes and tobacco production across various regions and below are the key takeaways. Read on to learn more about how the marketability of cigarette and tobacco products will be in the future.

pic1                                                            Source

Market Estimates and Forecasts

According to our industry experts, the cigarette and tobacco products industry has been performing well over the past five years, despite regulatory changes. Driven mainly by the cigarette segment, global cigarette consumption is expected to witness tremendous growth. As per our market intelligence report, the global tobacco market is generating huge profits, and the market is expected to surpass US$1,000 billion by 2018 despite the advent of innovative substitutes and various government campaigns against smoking and other tobacco-based products. Our research shows that the largest cigarette consuming countries so far have been China, Russia, US, Indonesia, and India followed by Europe and EMEA.

pic2

Source

Trends in Developed Vs. Developing Countries

The tobacco market is growing at a steady rate despite the odds of media talking about the health implications of smoking. This is due to a growing number of smokers in the developing and under-developed countries. With increasing anti-smoking campaigns, cigarette sales continue to weigh down on industry operators in developed countries. Consequently, there has been a decrease in adult smoking population globally. At Infiniti Research, our key focus is to offer global corporations insights pertaining to stringent regulations on the sales revenue of cigarette and tobacco products.

pic3

Source

Our research on the cigarette and tobacco production shows that the level of competition among the key players is intense. To stand out in the competition, a tobacco-producing company can consider factors like product innovations, packaging innovations, price variation, and tar content. Many players also consider the design of cigarettes, chemicals in smoke, and innovating smokeless cigarettes to bring about product differentiation. Our global market reports offer industry analysis into the cigarette and tobacco industry at a global level. Our detailed assessment offers a brief description of the cigarette and tobacco market in North America and Australia and the current marketing activities for such products. Read our complete case study here.

pic4

Consolidation of healthcare

Market Intelligence Study on Antimalarial Drugs in Multiple Markets

Malaria, caused by Plasmodium, is responsible for more than a million deaths all over the world. As per WHO’s ten facts on malaria, nearly half of the world’s population is at risk of malaria. Consequently, there is a need to identify and develop antimalarial therapeutics. At Infiniti Research, our experts performed a market intelligence study to understand the demand-supply landscape of the antimalarial treatment market across tropical countries. Governments have also implemented various elimination strategies to reduce the number of patients suffering from the disease.

Below are top trends about antimalarial drugs in various markets.

  1. The global antimalarial drug market to decline between 2014-2018 across regions as the number of patients suffering from malaria is decreasing.

Antimalarial drugs are used for the prevention of malarial infections. These drugs target the erythrocytic stage of malaria infection. Due to several international bodies and federal governments taking preventive measures to control the disease, there has been a stark decline in the demand for antimalarial drugs. Also, early diagnosis and treatment add to the above reason. Our experienced market potential assessment team at Infiniti Research tracked recent developments and innovations in the market through a meticulous process of collecting and analyzing information from exhaustive primary and secondary research methodologies.

  1. Nigeria – The leading market for antimalarial drugs in 2014, followed by DRC and Indonesia.

Young children, pregnant women, and travelers from malaria-free areas are vulnerable to the disease. Access to diagnostic centers and treatment are the major concerns for the African population. Malaria was a major public health issue in Nigeria, the DRC, Uganda, and Ghana, which reported several cases and deaths related to the disease in 2013. Our analysts spoke to stakeholders responsible for the sales and distribution of antimalarial drugs to understand how the market would perform in the short and long term across various regions.

By evaluating a broad range of published literature to develop an initial hypothesis, Infiniti’s market potential assessment team approached numerous market stakeholders and conducted in-depth primary and secondary research to determine the prescription patterns, key treatment methods used, and the trends affecting the antimalarial drugs market.

Read our complete case study to learn more about how to strategize effective market entry strategies for antimalarial drugs in multiple markets.

rheumatology

Global Challenges and Trends in Rheumatology

Rheumatology is a field of medicine which focuses on the diagnosis and treatment of various musculoskeletal diseases. With the growing geriatric population, instances of rheumatic and musculoskeletal diseases (RMDs) are on the rise. This spurs the need for more rheumatology centers and an increase in the global practice of rheumatology. People with RMDs experience severe joint pain, chronic pain and increasing disability. The increase in the number of rheumatology centers can be attributed to the preference for early diagnosis and treatment of RMDs. At Infiniti Research, our team of experts engaged in a market opportunity assessment to identify and profile the top rheumatology centers across North America and Europe. We have listed top challenges that are stressing out the rheumatology field.

  1. Surpassing Insurance and Reimbursement Problems – Our market intelligence study shows that there are huge limitations in insurance coverage and their financial impact among rheumatoid arthritis (RA) patients. Arthritis as a preexisting condition proved to limit the ability to earn a living. Not just that, many patients have been denied insurance for the same reason and had a considerable financial impact.

  1. Challenges Within Rheumatology Centers – A well-equipped rheumatology center offers people-centric care. Availability of such centers, affordability of the care offered and clinical services are few of the many arising challenges in this field. Any disparity created only prevents the early diagnosis of RMDs and delays the whole process. To help the client identify some of the critical issues faced by investors in this market space, our experts created a master list of rheumatology centers that would serve as a market map for each country and act as a decision support tool to determine the marketability of their medical devices and services in each country.

  1. Successful Early RA Diagnosis –Untreated RA has a greater chance of permanent joint disability. Early diagnosis and treatment for RA make all the difference. Rheumatologists today set specific goals and milestones to treat RA. Although experts realize the importance of early diagnosis, it’s also important to gather the right information during their first visit. Beyond treatment, there are great lifestyle changes that are suggested by rheumatologists. A balance of exercise and diet is the best thing to do if one’s diagnosed with early stage RA.

At Infiniti Research, our industry experts – who have extensive experience in healthcare, medical devices, and pharmaceutical verticals across the globe, follow a two-step research methodology to help you make the right investment decisions to ameliorate ROIs. Our approach involves an analysis of the major rheumatology centers for each country under focus and an assessment of the major profiles for rheumatology centers.

To learn more about the trends and market challenges, read our complete case study here.

camera

360 Degree View of Cameras for the Indian Real Estate Market

The real estate industry in India is growing one brick at a time. Being one of the most globally recognized industries, it’s expected to increase at a compound annual growth rate (CAGR) of over 11%. This includes the demand for both commercial and residential spaces. Despite demonetization and other reforms, the Indian real estate sector seems to be much more transparent than ever. At Infiniti Research, our experts performed a market intelligence study to help potential clients in the real estate market understand the usefulness of 360-degree cameras  in their ventures.

graph

Source

How Did the Real Estate Market Evolve in India?

A decade back, a real estate agent would be the sole keeper of all the information about any property. Anyone looking to either buy or sell their property would look for agent’s support. However, when the Internet took the world by storm, the real estate market steadily moved from offline to online channels. Online listing companies took over the highly unorganized agents’ or broker market. The demand for reliable realtors and verified listings reduced the need for agents. Not just that, many sellers and buyers could make their decision without any intervention of the brokers. pic1

360 Degree View of Properties – Your USP

With the evolution of internet also came many players. Our market intelligence study identified the top five web portals and highlighted some of the key players who utilized 360-degree cameras  to stand out from their peers. With the cut-throat competition, there was a strong need for these web portals to stand out. Having a 360-degree view of the property helps buyers virtually view the locality from anywhere through the Internet. And this clearly made path for 360-degree cameras  in the Indian real estate market. Our detailed case study also covers the technology and pricing aspects of 360-degree cameras.

Futuristic Insights for 360-Degree View Technology

A 360-degree cameras  shoots a video simultaneously from all the angles converting it to a landscape image. According to our research, the demand for 360-degree view in real estate industry is on the rise. Currently only one web portal offers 360 view images, and the company claims that they are still in an experimental phase, giving room for other players to venture in.

pic2

Our actionable market intelligence study, performed by the experts at Infiniti Research, talks about the current market scenario, key market players, and the importance of 360-degree view images. With increasing internet penetration in all the industries, this trend is sure to stay put.

Though various industries are making the most of the 360-degree technology, it is always a wise choice to understand the challenges as well. At Infiniti Research, all our services are backed by real-world data points and industry experts’ opinions.

To gain more insights on the future of 360-degree technology, read our latest market intelligence study on the 360-degree cameras  here.

capture

Is Lithium-Ion Battery Ideal for the Automotive Industry?

The global lithium-ion battery market is a fast-growing market space and was valued at over USD 18 billion in 2015. According to our industry experts, this market is envisaged to grow at a CAGR of over 8% by the end of 2020. With the growing focus on electric vehicles, the lithium-ion battery market is sure to charge ahead. Lithium-ion, the most promising battery chemistry, came in the limelight in the early 1970s. Due to its low maintenance cost, these types of batteries have an edge over the other chemistries.

At Infiniti Research, we recently engaged in a market intelligence study on automotive lithium-ion batteries for a global automotive manufacturer and here are the key excerpts of that engagement.

The Forecast of Lithium-Ion Batteries in the Automotive Industry

Infiniti’s experienced automotive team performed a market intelligence study to understand the lithium-ion battery market and its industry demand. During the course of the research, it was noted that the industry is poised to witness significant growth in the coming years with the automotive segment exhibiting faster progress. The recent increase in the incidence of global warming causing has led to a decline in natural resources and has warranted the need for alternate sources in the automotive industry. Not just that, the soaring prices of fossil fuels have helped the lithium-ion battery market to flourish. Manufacturers in the automotive industry are looking for sustainable clean fuels, and this is a key factor driving the lithium-ion battery industry.

Li-Ion

Lithium-Ion Batteries and its Automotive Applications

With the growing pressure on various countries to reduce their carbon emissions, the automotive industry is turning towards electric vehicles. Lithium-ion is the preferred battery technology when it comes to electric or hybrid vehicles. Its higher energy density, ability to churn out more charge cycles are just a few of the many reasons to treat lithium-ion batteries with respect. Much of these can be attributed to the rising demand for automotive Lithium-ion batteries from the motorsports industry and its ability to supplement the 12V net for high-power applications such as electric power steering (EPS), brake-by-capture wire (BBW) and heating, ventilation and air-conditioning (HVAC) systems.

The Market Drivers and Challenges

Many market players have entered the lithium-ion market due to its high growth potential. The current scenario is chaotic as many end-users are still not aware of the risks and challenges in the lithium-ion battery market. According to our automotive industry experts, one of the key drivers for this market is the fact that all lithium-ion batteries are equipped with individual electronic protections to avoid electrical mishaps (minimum and maximum voltage protection, current protection, etc.).

Battery1

One of the major challenges that has been identified by our analysts is its restriction during transportation, especially by air, as batteries transported by air must be protected against short circuits using protective covers. Also, the total product cost of this battery is around 40% higher than its former counterpart nickel-metal hydride batteries.

battery 2

Our industry specialists conducted a detailed market and competitive analysis on the 12V Lithium-Ion Battery market and 48V Lithium-ion Battery market. As part of this market intelligence study, we segmented the market by application, qualification, and the assembly. Additionally, an overview of the value chain for lithium-ion battery systems and lithium-ion battery components was also offered to the client. In 2015, Europe accounted for around 18% of the Global Lithium-ion Battery market.

AUTOMOTIVE LITHIUM-ION BATTERIES

To gain more insights on the latest trends and challenges

read our complete case study here.

capture

Health Economics for Medical Device Developers

The medical device industry is driven by optimistic device companies in the U.S., Europe, and Asia that seek innovation. With new innovations, the key stakeholders in the medical device market will keep funding research and new ideologies to bring about product differentiation. From the demand for self-medication to in-home healthcare services, the medical device industry is witnessing a change in preferences. Currently, the industry is going through a huge strategic change with respect to the development and launch of new products. And our health economists are here to help decode the trends for all the medical device developers.

Health economics plays a vital role in demonstrating the value of new products launched by medical device manufacturers. In general, there are two main areas to focus – Medical Device Reimbursement and Market Access. Involving health economics early in the process will help businesses assess product development opportunities. At Infiniti Research, our experts will leave you with compelling reasons to choose health economics for the medical device industry.

Let Data Do the Talking

Create a comprehensive reimbursement plan for medical devices with the help of health economics analysis from a payers’ perspective. A detailed health economics analysis will give you insights on providing quality care for more people by reducing costs. This will help decision makers to conclude how effective the proposed medical device is over the existing ones and its value for money. This will also prevent the development of technologies and devices that have doubtful value in the future.

Make Well-informed Decisions

Expenditure in the medical device industry is substantially growing. There is an extensive government intervention when it comes to norms and regulations to promote the efficient use of medical devices. This is where an economic evaluation of medical devices will keep every medical device manufacturer informed about the pricing and reimbursement plans. Not just that, it will demonstrate the cost-effectiveness of new and emerging medical devices to make sound decisions.

Rethink Reimbursement

Cost-effectiveness of medical devices plays a huge role when it comes to reimbursement. If there exists therapy A and a new therapy B and they both seem to have similar clinical outcomes, preference will be given to the therapy that is more cost efficient. However, this choice of treatment can be debated if therapy B is much more effective than A. As a medical device manufacturer, you can save time and money when you rethink reimbursement.

As a medical device manufacturer, it is a wise choice to analyze the health economics for the newly developed medical device. Right from assessing the commercial viability of the device to avoiding frugal innovations, the device will have its reimbursement strategies explored. Other than that, a developer can make a better, informed product design ruling out unpromising technologies.

Whether you’re a strategy expert or a decision maker, here is our case study.

Medical Reimbursement, Health Economics, and Market Access Mapping for Wound Care Dressings.
capture

COPD – Major Health Problem in Europe, Strike it Out With NIV!

COPD – Chronic obstructive pulmonary disease is expected to increase from almost 270,000 in 2005 to 338,000 deaths by 2030. Often COPD is under diagnosed, inferring that the prevalence rates are only going to increase. Recently, Infiniti Research performed a market assessment on COPD and Non-Invasive Ventilation (NIV) treatment for the European market, and here are some insights from our market assessment for medical device manufacturers specializing in NIV to help them develop effective market entry strategies.

NIV to Witness Robust Growth

A recent market assessment study shows that COPD is the major cause of death, whose prevalence is on the rise and is envisaged to be the third leading cause of death globally by 2030. Furthermore, patients getting affected are on the aging side; as a result of which, physicians prefer non-invasive techniques over the invasive ones. The recent rise in chronic respiratory diseases has increased the demand for the right medical device supplies. Since the market witnesses a surge in the popularity of ventilators our industry experts feel that this would be the right time for the medical device manufacturers to take a plunge in this industry. Other than COPD, NIV has also been successfully used in patients with acute respiratory distress syndrome (ARDS) and postoperative and post-transplantation respiratory failure, reducing intubation rates, ICU stays, and the overall mortality rate.

Recent Developments and Opportunities

The advantages that NIV treatment offers is tremendous. One of the key areas for the vendors in Europe to target is the private sector. With medical device reimbursement getting strict, NIV has the edge over the other treatments and the reimbursement guidelines look promising. This trend is catching up and is sure to prevail in the UK as well. Our market assessment was focused at countries such as the UK, France, Italy, Germany, Spain, Sweden, Norway, Switzerland, Denmark, Portugal, and Finland. A research on first-line NIV treatment was associated with a decrease in 60-day mortality rate from 27 to 9% throughout the study period. The incidence of increasing chronic respiratory diseases and NIV treatment reducing the mortality rate shows the perfect balance in the medical device industry.

The Futuristic View of NIV Treatment

Other than the private sector, if you’re an NIV treatment vendor, home care ventilation is another booming sector to watch out for.  Most of the patients suffering from COPD are suggested home ventilation by the physicians, thus, leading to the reduction in the length of stays in hospitals. Tapping the home care market will ensure high returns when it comes to home care ventilation. Not just that, with the high risk associated with hospital-acquired infections, home care ventilators are a great choice to stay safe and healthy.

How We Help in Smarter Decision Making

Being the preferred partner for more than 55 Fortune 500 firms, we can help any leading global respiratory device manufacturer make the right decision about exploring the untapped sectors. In a recent market assessment engagement, we helped a global pharmaceutical conglomerate evaluate the prevalence and magnitude of COPD and global initiative for chronic obstructive lung disease (GOLD) across 10 European countries. During the course of this research, it was found that with the growing rate of COPD, sleep apnoea, and other respiratory disease, the usage of NIV treatment in both hospitals and home care segment is sure to go sky high.

Here is a successful market assessment case study on how we helped a leading global respiratory health products manufacturer make the right decision when it comes to market entry. You can read the complete case study here!

Capture

Pain-Free Reimbursement Pathways for Wound Care Dressings

With path-breaking growth in innovative technologies, the medical device industry is here to stay. In terms of key products, this industry consists of medical devices like orthopedic instruments, surgical instruments, diagnostic apparatuses, stents and catheters, syringes and hypodermic needles and intravenous equipment. Hospitals and physicians use a wide array of medical devices, but it must be noted that it’s the public and private payers who reimburse and set the rules. Having the right medical device reimbursement strategy in place will help your business stay ahead of competitors by understanding the profitability of products. Not just that, it will also ensure that companies have a great revenue stream and profitability for new technologies.

In the wound care industry, getting insights into the right medical device reimbursement pathway is important for ameliorating sales growth in the future. Whether you’re venturing into the medical device industry or a medical device company, you can count on us to help you make the right decision. At Infiniti, we give you insights into the 5 top ways on how to work on your medical device’s reimbursement.

  1. Plan right from the design phase – Your medical device reimbursement assessment starts right when you design the type of wound care dressing. This is where our medical device reimbursement consultants will thoroughly analyze the impact on product design and its sales.
  1. Be prepared for the shortfalls – Fee-for-Service (FFS) medical reimbursement model and value-based purchasing (VBP) medical reimbursement are some of the limitations faced by the professionals in the industry.
  1. Think from a medical director’s perspective – If you’re having a tough time getting the right coverage for your wound care dressings, it’s time to feel their pain. Market your product to a payer. Anticipate their objections.
  1. Analyze country-specific reimbursement pathways – Though the reimbursement pathways are easier to navigate because they are often single-payer, government-based systems, coverage decisions are made by the local Medicare Administrative Contractors (MACs). Get your personalized analysis of location-specific reimbursement pathways here.
  1. Broaden your spectrum – When you develop a new wound care dressing product, try not to focus on the clearance only from the U.S. Food and Drug Administration (FDA). But, also try and meet requirements from Current Procedural Terminology (CPT, a registered trademark of the American Medical Association) and/or Healthcare Procedure Coding System (HCPCS) codes.

 

If you’re a medical equipment company, we understand how crucial it is to obtain coverage and funding for your healthcare products. At Infiniti, our medical device reimbursement consultants are here to assist you effectively. With the help of our market assessment plan, innovation tracking and stakeholder intelligence, you’re sure to get your medical device reimbursement plan in place and gain strategic insights into the wound care dressings industry.

Want to know how we helped a global medical device manufacturer improve ROIs for their products?

Read more here

capture

Cost-Saving Ideas for the Future of American Healthcare

Healthcare in the United States is presently facing turmoil and uncertainty. As Donald Trump and the Republican Party attempt to repeal the Affordable Care Act—nicknamed ‘Obamacare’—those in need of health care in the country are left with many questions. What will replace Obamacare? How will access to the healthcare system change? What will the cost be to individuals? Moreover, how will this supposed healthcare reform impact the healthcare industry financially?

While some of these burning questions will remain unanswered for some time, what we can ascertain is that there are many ways the healthcare industry can cut costs to become more effective and save money in these turbulent times. Here are some small but significant ways for the healthcare industry to save money:

  1. Reduce use of anesthesia providers: According to RAND Health, roughly USD 1.3 billion was spent on anesthesia providers during gastrointestinal procedures in 2009. However, only roughly USD 0.2 billion was spent on high-risk patients. Reducing anesthesia use and anesthesia providers for low-risk patients could potentially save over USD 1 billion dollars.
  2. Adopt ultrasound guidance: Using ultrasound guidance for central line placement helps to avoid catheter complications and errors during insertion. According to RAND, reducing errors can result in savings of over USD 50 million.
  3. Modernize communications equipment: Too many hospitals and doctors’ offices are still using outdated technology such as fax machines and early-2000s scanners. Modernizing equipment will allow for faster and more effective communication between staff and patients and between healthcare providers. Modern, high-quality equipment will also have greater compliance with digitized medical records and will eliminate many repair costs.
  4. Ensure as many patients as possible have health insurance: If Trump’s mysterious new plan (Trumpcare?) is in any way similar to Obamacare, as many speculate that it could be, ensuring high enrolment numbers is essential to keeping costs down for a large number of people.
  5. Increase diagnostic efficiency: Adopting more effective and advanced diagnostic methods, techniques, and machinery will allow healthcare providers to make diagnoses with greater accuracy. Reducing misdiagnoses and allowing more patients to receive the right treatment will save money in the long term.
  6. Encourage use of generic drugs: Policies encouraging the use of less expensive generic drugs will benefit the patients and the healthcare system as a whole, resulting in cost savings and increased and more affordable access to necessary treatment.
  7. Increase regular inspections of healthcare facilities: Inspecting healthcare facilities on a regular basis and ensuring that they are adhering to regulation, law, and the health code will promote trust between facilities and patients. Such inspections will go a long way to protect the public, resulting in greater patient retention and the number of patients who are choosing to opt in for healthcare.
  8. Reduce risk of HAI: According to the CDC, there were 721,800 cases of hospital-associated infection (HAI) in 2011. Patients undergoing central line, catheter, or ventilator related treatments are often at risk for infection. Preventing infection by increasing hand hygiene, barrier precautions, and antibiotic use, amongst other things, will result in significant cost savings for the industry.
  9. Increase preventative measures for patients: Increasing preventative procedures and exams, such as colonoscopies and mammograms, will save money in the long term by working to prevent serious cancers and other diseases that require intensive and expensive treatment.
  10. Price and quality transparency: According to Fortune, market competition can work to control healthcare costs just as it works to control costs in other industries. Hospitals and other healthcare providers being transparent about their costs will create competition, encouraging hospitals to improve and strive to meet patient needs. It will also save patients money as they will be able to select the most affordable treatment and hospital for themselves.

 

In the coming days and weeks, we can expect to see where Donald Trump intends to take the future of the US healthcare system and whether or not his proposed healthcare reform will implement cost saving ideas for the healthcare industry and patients alike. Hopefully, healthcare providers in the US will be able to benefit, reduce costs, and work towards more effective treatment and a healthier population.

 

 

 

capture

Navigating Through the Future of Medical Devices – A Webinar Addressing the Critical Issues Faced by Medical Device Manufacturers in 2017

A key strategy to stay ahead of the curve in today’s dynamic medical device market is to become “agile innovators.” Medical device companies that adapt to these trends will find enormous opportunities to grow and thrive.

 

The process of introducing medical devices to markets across the globe can be complex, requiring an understanding of premarket preparation, and approval to the Food and Drug Administration (FDA). Furthermore, with the advent of various micro and macro trends such as enhanced buying power of payers or providers, complex regulatory scrutiny, and the introduction of new healthcare delivery models, medical device manufacturers have been struggling captureto develop effective market entry strategies. Recently, for instance, the industry’s key influencers have sounded upbeat about the Republican Congress and the new Trump administration during recent interactions with analysts. And while there are many open questions, top executives insist that the potential repeal and replacement of the Affordable Care Act may not have a massive impact on the sales volumes of medical devices across certain regions.

Our medical device industry experts feel that a key to dealing with the dynamism of the medical devices industry is “becoming agile innovators.” With payers’ increasing focus on value-based reimbursement and health systems’ continuing interest in outpatient services and home care services, the landscape for the healthcare industry will likely through a massive change. “Medical device companies that adapt to these trends will find enormous opportunities to grow and thrive,” says Vivek Sikaria, AVP: Market Intelligence and Advisory at Infiniti Research.

In our webinar, which was held on the 22nd and 23rd of February, the speakers focused on how the lower probability of earning premium margins by merely selling standard clinical features and new devices into existing market spaces would create significant pressure for strategy experts to identify new markets to sell their solutions. The identification of such segments or open markets where they can sell their end-to-end solutions, helped key decision makers secure additional revenue and maintain market shares.

Here’s an insight into the top four questions addressed by our speakers:

 

  • What parameters should you consider while assessing demand across new markets?
  • How to accurately predict demand for your new medical device product or technology?
  • Traditional models of market estimation V/s the best practices. Which is better?
  • How to track the market performance of emerging medical devices or technologies?